Dynavax Technologies (DVAX) | Stock Overview & Key Data
Dynavax Technologies Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: $106.60 on November 27, 2006
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Financial Highlights
Profitability
Returns and Earnings
Growth
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Dynavax Technologies DVAX | 1.27B Small-cap | 6.40% | 5.16% | -10.14% | -14.41% | -16.20% | -1.49% | -26.76% | -6.86% |
| Zoetis ZTS | 70.27B Large-cap | 2.18% | -6.53% | -0.27% | -2.53% | -2.11% | -9.02% | -10.56% | 16.11% |
| Haleon Plc - ADR HLN | 45.53B Large-cap | -2.05% | -7.63% | 4.15% | 10.44% | 6.46% | 12.92% | 35.63% | 35.63% |
| Supernus SUPN | 1.77B Small-cap | 1.87% | -1.80% | 2.87% | -12.86% | -10.32% | 12.12% | 8.12% | 32.60% |
| Indivior PLC INDV | 1.92B Small-cap | -1.69% | 12.73% | 56.24% | 27.76% | 21.12% | 39.94% | 323.74% | 1,372.82% |
| Bausch Health BHC | 2.55B Mid-cap | -7.44% | 35.60% | 31.27% | -16.37% | -17.00% | -9.70% | -22.99% | -62.90% |
Ownership & Short Interest
Dynavax Technologies Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Dynavax Technologies would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
What is DVAX's 52-week high and low?
In the last 52 weeks, Dynavax Technologies reached a high of $14.63 (on March 7, 2025) and a low of $9.22 (on May 14, 2025).
What is the market cap and P/E ratio for DVAX?
Curious about Dynavax Technologies's size and valuation? Its market capitalization stands at 1.27B. When it comes to valuation, the P/E ratio (trailing twelve months) is 54.60, and the forward P/E (looking ahead) is 29.39.
Does DVAX pay dividends? If so, what's the yield?
As for dividends, Dynavax Technologies isn't currently offering a significant yield, or that specific data isn't available right now.
Who are Dynavax Technologies's main competitors or similar companies to consider before investing?
When looking at Dynavax Technologies, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
| Company | Mkt Cap | Sector | Industry | 1Y Return | 3Y Return |
|---|---|---|---|---|---|
| Zoetis ZTS | 70.27B | Healthcare | Drug Manufacturers - Specialty & Generic | -9.02% | -10.56% |
| Haleon Plc - ADR HLN | 45.53B | Healthcare | Drug Manufacturers - Specialty & Generic | 12.92% | 35.63% |
| Supernus SUPN | 1.77B | Healthcare | Drug Manufacturers - Specialty & Generic | 12.12% | 8.12% |
| Indivior PLC INDV | 1.92B | Healthcare | Drug Manufacturers - Specialty & Generic | 39.94% | 323.74% |
| Bausch Health BHC | 2.55B | Healthcare | Drug Manufacturers - Specialty & Generic | -9.70% | -22.99% |
For a more comprehensive list, please see the Peer Performance Comparison table on this page.
What are the key financial health indicators for Dynavax Technologies Corporation? (e.g., ROE, Debt/Equity)
To get a sense of Dynavax Technologies's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -10.45%, the Debt to Equity ratio from the most recent quarter is 54.64, and its Gross Profit Margin stands at 79.80%.
What is the recent revenue and earnings growth for DVAX?
Looking at Dynavax Technologies's growth, its revenue over the trailing twelve months (TTM) was $295M. Compared to the same quarter last year (YoY), quarterly revenue grew by 34.20%, and quarterly earnings saw a YoY growth of 34.21%.
How much of DVAX stock is held by insiders and institutions?
Wondering who owns Dynavax Technologies stock? Company insiders (like executives and directors) hold about 0.59% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 108.60%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.